The New York Health Department has issued final regulations for a statewide medical marijuana program expected to start next year.
The 121 pages of details posted online follow the law signed last July authorizing patients with certain diseases to be able to obtain non-smokeable versions of the drug, which can be ingested or vaporized.
Conditions include cancer, AIDS, Lou Gehrig's disease, Parkinson's disease, multiple sclerosis, certain spinal cord injuries, epilepsy, inflammatory bowel disease, neuropathies and Huntington's Disease.
They call for licensing five businesses or nonprofits in New York to grow and distribute the drug.
Applicants have to pay a $10,000 fee for review. Those selected would pay an additional $200,000 registration fee and meet security guidelines. The licenses would be for two years.
